Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology
- PMID: 17273114
- DOI: 10.1097/01.PCC.0000257100.31779.41
Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology
Abstract
Objective: To provide a general descriptive account of the end-organ effects of dexmedetomidine and to provide an evidence-based review of the literature regarding its use in infants and children.
Data source: A computerized bibliographic search of the literature regarding dexmedetomidine.
Main results: The end-organ effects of dexmedetomidine have been well studied in animal and adult human models. Adverse cardiovascular effects include occasional episodes of bradycardia with rare reports of sinus pause or cardiac arrest. Hypotension has also been reported as well as hypertension, the latter thought to be due to peripheral alpha2B agonism with peripheral vasoconstriction. Although dexmedetomidine has no direct effects on myocardial function, decreased cardiac output may result from changes in heart rate or increases in afterload. There are somewhat conflicting reports in the literature regarding its effects on ventilatory function, with some studies (both human and animal) suggesting a mild degree of respiratory depression, decreased minute ventilation, and decreased response to CO2 challenge whereas others demonstrate no effect. The central nervous system effects include sedation and analgesia with prevention of recall and memory at higher doses. Dexmedetomidine may also provide some neuroprotective activity during periods of ischemia. Applications in infants and children have included sedation during mechanical ventilation, prevention of emergence agitation following general anesthesia, provision of procedural sedation, and the prevention of withdrawal following the prolonged administration of opioids and benzodiazepines.
Conclusions: The literature contains reports of the use of dexmedetomidine in approximately 800 pediatric patients. Given its favorable sedative and anxiolytic properties combined with its limited effects on hemodynamic and respiratory function, there is growing interest in and reports of its use in the pediatric population in various clinical scenarios.
Similar articles
-
Bradycardia during dexmedetomidine and therapeutic hypothermia.J Intensive Care Med. 2008 Nov-Dec;23(6):403-8. doi: 10.1177/0885066608324389. J Intensive Care Med. 2008. PMID: 18794167
-
Review article: Dexmedetomidine in children: current knowledge and future applications.Anesth Analg. 2011 Nov;113(5):1129-42. doi: 10.1213/ANE.0b013e31822b8629. Epub 2011 Aug 4. Anesth Analg. 2011. PMID: 21821507 Review.
-
Adjunctive dexmedetomidine therapy in the intensive care unit: a retrospective assessment of impact on sedative and analgesic requirements, levels of sedation and analgesia, and ventilatory and hemodynamic parameters.Pharmacotherapy. 2007 Mar;27(3):351-9. doi: 10.1592/phco.27.3.351. Pharmacotherapy. 2007. PMID: 17316147
-
Dexmedetomidine: applications for the pediatric patient with congenital heart disease.Pediatr Cardiol. 2011 Dec;32(8):1075-87. doi: 10.1007/s00246-011-0092-8. Epub 2011 Sep 10. Pediatr Cardiol. 2011. PMID: 21909772 Review.
-
Dexmedetomidine: an updated review.Ann Pharmacother. 2007 Feb;41(2):245-52. doi: 10.1345/aph.1H314. Epub 2007 Feb 13. Ann Pharmacother. 2007. PMID: 17299013 Review.
Cited by
-
Dexmedetomidine: Are There Going to be Issues with Prolonged Administration?J Pediatr Pharmacol Ther. 2010 Jan;15(1):4-9. J Pediatr Pharmacol Ther. 2010. PMID: 22477787 Free PMC article. No abstract available.
-
Dexmedetomidine to control agitation and delirium from toxic ingestions in adolescents.J Pediatr Pharmacol Ther. 2010 Jan;15(1):43-8. J Pediatr Pharmacol Ther. 2010. PMID: 22477792 Free PMC article.
-
Sedation strategies in children with pediatric acute respiratory distress syndrome (PARDS).Ann Transl Med. 2019 Oct;7(19):509. doi: 10.21037/atm.2019.09.16. Ann Transl Med. 2019. PMID: 31728362 Free PMC article. Review.
-
Effectiveness and Safety of Dexmedetomidine in Neonates With Hypoxic Ischemic Encephalopathy Undergoing Therapeutic Hypothermia.J Pediatr Pharmacol Ther. 2024 Jun;29(3):232-240. doi: 10.5863/1551-6776-29.3.232. Epub 2024 Jun 10. J Pediatr Pharmacol Ther. 2024. PMID: 38863848 Free PMC article.
-
Dexmedetomidine Infusion to Control Agitation due to Anticholinergic Toxidromes in Adolescents, a Case Series.J Pediatr Pharmacol Ther. 2015 Jul-Aug;20(4):329-34. doi: 10.5863/1551-6776-20.4.329. J Pediatr Pharmacol Ther. 2015. PMID: 26380573 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical